Cargando…
Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
Autores principales: | Song, Wei, Tang, Lin, Xu, Yumei, Xu, Jing, Zhang, Wenwen, Xie, Hui, Wang, Shui, Guan, Xiaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353734/ https://www.ncbi.nlm.nih.gov/pubmed/28300203 http://dx.doi.org/10.1038/srep44346 |
Ejemplares similares
-
PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
por: Song, Wei, et al.
Publicado: (2017) -
The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
por: Luo, Jiayan, et al.
Publicado: (2016) -
Corrigendum: PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA
por: Day, Tovah A., et al.
Publicado: (2017) -
Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2017) -
Corrigendum: MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells
por: Lai, Xianning, et al.
Publicado: (2017)